In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The fifth and final match of the five-match Test series between India and Australia is being play
Even though the second wave of corona in the country seems to be stopping, but the railways are b
'Modi Ji is the king and there is police rule in India', arrests Rahul Gandhi attacks the Center
Congress leader Rahul Gandhi was detained by Delhi Police on Tuesday. Rahul along with other Cong
Amidst the ongoing controversy between the world's richest man Elon Musk and the micro-blogging s
IPL 2025: BCCI's big decision amid India-Pakistan tension, IPL 2025 season postponed indefinitely
The Board of Control for Cricket in India (BCCI) has taken a big decision on Friday amid the ongo
Today i.e. 25 April 2023, on Tuesday, the doors of Kedarnath Dham have been opened. As soon as th
Bahubali star Prabhas' film 'Adipurush' may not have been successful at the box office, yet the c
IT Raid: Income tax raid on educational institutions of Bangalore, early morning action
On Thursday morning, several educational institutions in Bengaluru were raided by the Income Tax
Millions of cases of corona infection are coming to light in China. Meanwhile, the Chinfing gover
Anil Ghanwat Exclusive Interview: Farmer leader Rakesh Tikait is adamant about continuing the agi
